z-logo
open-access-imgOpen Access
The perils of artificial intelligence in healthcare: Disease diagnosis and treatment
Author(s) -
Caroline Jung
Publication year - 2019
Publication title -
journal of computational biology and bioinformatics research
Language(s) - English
Resource type - Journals
ISSN - 2141-2227
DOI - 10.5897/jcbbr2019.0122
Subject(s) - personalized medicine , health care , artificial intelligence , big data , precision medicine , applications of artificial intelligence , computer science , data science , deep learning , genomics , fallacy , disease , genome , medicine , bioinformatics , biology , data mining , biochemistry , philosophy , epistemology , pathology , gene , economics , economic growth
For the past decade, artificial intelligence (AI) and its related technologies have made remarkable advances in marketing and business solutions based on AI-driven big data analysis of customer queries, and it, when coupled with bioinformatics, seemingly holds out great promise for use in healthcare. In reality, however, AI is still largely a buzzword when it comes to disease diagnosis and treatment. This review addresses the uncertainty of AI applications to disease diagnosis and treatment, not only pinpointing AI’s inherent algorithmic problems in dealing with non-patternable stochastic healthcare data, but also revealing the innate fallacy of identifying genetic mutations as a tool for genome-based personalized medicine. Finally, this review concludes by presenting some insights into future AI application in healthcare.   Key words: Artificial intelligence, machine learning, deep learning, bioinformatics, healthcare, genomic medicine, personalized medicine, reference genome, genetic variation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom